This week news of deaths
caused by patients taking a test drug called Pacritinib has hit the
headlines.
The drug was being tested to
treat a rare blood cancer called myelofibrosis. Sadly, volunteers in locations
across the world have suffered from brain haemorrhages or heart failure. And
several people have died, including one Britain.
The phase III trial has now
been halted according to
The Sunday Times.
Worryingly, the French
authorities are refusing to release more information about the drug and its
testing. There are unconfirmed reports that chimpanzees and dogs
were used in animal tests first. There are also reports that the dogs
became ill and died during the experiments.
Geen opmerkingen:
Een reactie posten